Glioma subtype may hold the secret to the success of immunotherapies

A common mutation in gliomas sensitizes them to immunotherapy, a finding which researchers believe could have broader therapeutic implications for all glioma patients.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210929154202.htm
Glioma subtype may hold the secret to the success of immunotherapies Glioma subtype may hold the secret to the success of immunotherapies Reviewed by cmakigo on September 30, 2021 Rating: 5

No comments:

'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.